These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 24974340)

  • 1. Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.
    Yun J; Han M; Song C; Cheon SH; Choi K; Hahn HG
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3234-7. PubMed ID: 24974340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploration of novel 3-substituted azetidine derivatives as triple reuptake inhibitors.
    Han Y; Han M; Shin D; Song C; Hahn HG
    J Med Chem; 2012 Sep; 55(18):8188-92. PubMed ID: 22938049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biaryl analogues of conformationally constrained tricyclic tropanes as potent and selective norepinephrine reuptake inhibitors: synthesis and evaluation of their uptake inhibition at monoamine transporter sites.
    Zhou J; Zhang A; Kläss T; Johnson KM; Wang CZ; Ye YP; Kozikowski AP
    J Med Chem; 2003 May; 46(10):1997-2007. PubMed ID: 12723962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming hERG activity in the discovery of a series of 4-azetidinyl-1-aryl-cyclohexanes as CCR2 antagonists.
    Zhang X; Hufnagel H; Markotan T; Lanter J; Cai C; Hou C; Singer M; Opas E; McKenney S; Crysler C; Johnson D; Sui Z
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5577-82. PubMed ID: 21783361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1-(2-Phenoxyphenyl)methanamines: SAR for dual serotonin/noradrenaline reuptake inhibition, metabolic stability and hERG affinity.
    Whitlock GA; Blagg J; Fish PV
    Bioorg Med Chem Lett; 2008 Jan; 18(2):596-9. PubMed ID: 18240382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty acid amide hydrolase inhibitors. 3: tetra-substituted azetidine ureas with in vivo activity.
    Roughley SD; Browne H; Macias AT; Benwell K; Brooks T; D'Alessandro J; Daniels Z; Dugdale S; Francis G; Gibbons B; Hart T; Haymes T; Kennett G; Lightowler S; Matassova N; Mansell H; Merrett A; Misra A; Padfield A; Parsons R; Pratt R; Robertson A; Simmonite H; Tan K; Walls SB; Wong M
    Bioorg Med Chem Lett; 2012 Jan; 22(2):901-6. PubMed ID: 22209458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists.
    Gray DL; Xu W; Campbell BM; Dounay AB; Barta N; Boroski S; Denny L; Evans L; Stratman N; Probert A
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6604-7. PubMed ID: 19854053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression.
    Carter DS; Cai HY; Lee EK; Iyer PS; Lucas MC; Roetz R; Schoenfeld RC; Weikert RJ
    Bioorg Med Chem Lett; 2010 Jul; 20(13):3941-5. PubMed ID: 20570146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Synthesis and antidepressant activities of aryl alkanol piperidine derivatives].
    Zheng YY; Gao K; Weng ZJ; Li JQ
    Yao Xue Xue Bao; 2010 Mar; 45(3):324-9. PubMed ID: 21351508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple reuptake inhibitors: Design, synthesis and structure-activity relationship of benzylpiperidine-tetrazoles.
    Paudel S; Min X; Acharya S; Khadka DB; Yoon G; Kim KM; Cheon SH
    Bioorg Med Chem; 2017 Oct; 25(20):5278-5289. PubMed ID: 28807575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors.
    McComas CC; Vu AT; Mahaney PE; Cohn ST; Fensome A; Marella MA; Nogle L; Trybulski EJ; Ye F; Zhang P; Alfinito P; Bray J; Johnston G; Koury E; Deecher DC
    Bioorg Med Chem Lett; 2008 Sep; 18(18):4929-31. PubMed ID: 18771916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and in vitro activity of 1,4-disubstituted piperazines and piperidines as triple reuptake inhibitors.
    Paudel S; Acharya S; Yoon G; Kim KM; Cheon SH
    Bioorg Med Chem; 2017 Apr; 25(7):2266-2276. PubMed ID: 28274674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel N-aryl piperazine CXCR4 antagonists.
    Zhao H; Prosser AR; Liotta DC; Wilson LJ
    Bioorg Med Chem Lett; 2015 Nov; 25(21):4950-4955. PubMed ID: 25935642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.
    Carlier PR; Lo MM; Lo PC; Richelson E; Tatsumi M; Reynolds IJ; Sharma TA
    Bioorg Med Chem Lett; 1998 Mar; 8(5):487-92. PubMed ID: 9871604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.
    Shao L; Wang F; Malcolm SC; Ma J; Hewitt MC; Campbell UC; Bush LR; Spicer NA; Engel SR; Saraswat LD; Hardy LW; Koch P; Schreiber R; Spear KL; Varney MA
    Bioorg Med Chem; 2011 Jan; 19(1):663-76. PubMed ID: 21093273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel triple reuptake inhibitors with low risk of CAD associated liabilities: design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds.
    Ishichi Y; Kimura E; Honda E; Yoshikawa M; Nakahata T; Terao Y; Suzuki A; Kawai T; Arakawa Y; Ohta H; Kanzaki N; Nakagawa H; Terauchi J
    Bioorg Med Chem; 2013 Aug; 21(15):4600-13. PubMed ID: 23769168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of azetidinone acids as conformationally-constrained dual PPARalpha/gamma agonists.
    Wang W; Devasthale P; Farrelly D; Gu L; Harrity T; Cap M; Chu C; Kunselman L; Morgan N; Ponticiello R; Zebo R; Zhang L; Locke K; Lippy J; O'Malley K; Hosagrahara V; Zhang L; Kadiyala P; Chang C; Muckelbauer J; Doweyko AM; Zahler R; Ryono D; Hariharan N; Cheng PT
    Bioorg Med Chem Lett; 2008 Mar; 18(6):1939-44. PubMed ID: 18291645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor.
    Micheli F; Cavanni P; Andreotti D; Arban R; Benedetti R; Bertani B; Bettati M; Bettelini L; Bonanomi G; Braggio S; Carletti R; Checchia A; Corsi M; Fazzolari E; Fontana S; Marchioro C; Merlo-Pich E; Negri M; Oliosi B; Ratti E; Read KD; Roscic M; Sartori I; Spada S; Tedesco G; Tarsi L; Terreni S; Visentini F; Zocchi A; Zonzini L; Di Fabio R
    J Med Chem; 2010 Jul; 53(13):4989-5001. PubMed ID: 20527970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and docking study of 4-arylpiperazine carboxamides as monoamine neurotransmitters reuptake inhibitors.
    Paudel S; Sun N; Khadka DB; Yoon G; Kim KM; Cheon SH
    Bioorg Med Chem; 2018 Aug; 26(14):4127-4135. PubMed ID: 30007567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.
    Heffernan GD; Coghlan RD; Manas ES; McDevitt RE; Li Y; Mahaney PE; Robichaud AJ; Huselton C; Alfinito P; Bray JA; Cosmi SA; Johnston GH; Kenney T; Koury E; Winneker RC; Deecher DC; Trybulski EJ
    Bioorg Med Chem; 2009 Nov; 17(22):7802-15. PubMed ID: 19836247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.